Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
about
Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapyTacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results.Sirolimus in pediatric renal transplantation.FK506 nephrotoxicity.Sirolimus: continuing the evolution of transplant immunosuppression.mTOR inhibitors: an overview.Drug-associated renal dysfunction and injury.Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimusNew insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism.Rapamycin passes the torch: a new generation of mTOR inhibitors.Drug-induced alterations in Mg2+ homoeostasis.Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.Role of mechanistic target of rapamycin (mTOR) in renal function and ischaemia-reperfusion induced kidney injury.Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity.Sirolimus enhances cyclosporine a-induced cytotoxicity in human renal glomerular mesangial cellsSirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.Everolimus treatment downregulates renocortical cyclooxygenase-2 expression in the rat kidney.Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression.Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats.Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells.Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.The immunophilin FKBP52 inhibits the activity of the epithelial Ca2+ channel TRPV5.A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection.Effect of acute hyperinsulinemia on magnesium homeostasis in humans.Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.A Rapamycin-Activated Caspase 9-Based Suicide Gene.Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.Serum Magnesium after Kidney Transplantation: A Systematic Review.
P2860
Q24799790-4D7ACA5C-84B1-491D-9345-69D763CF3F2CQ31418325-0ED63E8F-5C85-4A8B-870E-923293993B2BQ33376348-574F682A-8998-4CA5-A795-538DCBAE027EQ33397668-62E54E68-3260-4997-8493-8522EDC95E78Q33693210-5668AAA5-F62C-401C-811E-EF60C5BA79AFQ34028674-2F816E19-68FD-4557-86FB-EA5C12532309Q34302240-6A568886-4CC6-4DA4-A868-09DE089082B4Q34560483-5A9FA80D-4D34-4FDE-B919-EA0E958D4EC4Q35827268-5751B6B1-E1E5-4D48-8717-168DFE4DD1D0Q36788871-E1ADE079-3694-4437-8CAD-E5418999683DQ37318737-D1300242-D1F9-4715-B9F1-415BBE5BF360Q37950771-888B7930-D073-40F9-9ADA-CCBAB0C4BCD9Q37992700-54E44180-F35C-4E03-8FA4-3A1D3755BADFQ38914374-97D2C00B-A122-4035-9040-9CF023ECD0EDQ39459761-D0D03679-FADD-4D71-BCCE-6681478C864EQ40709714-7405FE33-7A02-4EDA-955C-55D119120F48Q40793003-DCD56EA8-4AF9-4AAF-AC62-4D835AF19BC8Q42680562-4A6104D5-9CD9-4641-8E12-B280ED10DB49Q43022805-A85BB85D-ABA8-458F-93E9-D6E7AB84F7F2Q43231811-18943605-A882-45EB-82FD-97EE91676BA5Q43261412-5B553D88-4053-4173-BB4B-B5E4427187E5Q43298132-5FBCC6CA-FABD-48B5-BBD6-40C5A36464E5Q43546407-D97D9F73-F964-4898-B3E8-A7951AD8AF88Q43735102-52B2A912-D3DB-405F-8367-8E012D73F0F1Q44629535-ED913460-3339-424D-8B2A-A822F59E9E7BQ44854978-4F8B2BAD-4500-43C3-AAF4-EF39CBE74811Q46849941-44AC7473-C07B-490E-A652-6D5D3C64D44BQ46882764-017BE728-2597-4FAE-B1F9-442A8A694414Q48044608-972F2B98-4ACB-402A-9FAF-859F66FE7388Q49070652-CABF13B1-1A09-4D9F-930D-E146C6E907C7Q52584838-742CF556-8F72-48AA-9B82-48B839F5AA4DQ53201792-1E8A9DE8-FF12-4FD4-9243-80AC6614D065Q55447877-19FE6A8A-FDB5-4E4D-A0B5-6F54482B7F35
P2860
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@en
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@nl
type
label
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@en
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@nl
prefLabel
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@en
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@nl
P2093
P356
P1433
P1476
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
@en
P2093
Bennett WM
Burdmann EA
Fransechini N
Houghton DC
P2888
P304
P356
10.1038/KI.1996.417
P407
P577
1996-10-01T00:00:00Z